Literature DB >> 2760172

Hysteresis in the relationship between serum ionized calcium and intact parathyroid hormone during recovery from induced hyper- and hypocalcemia in normal humans.

P R Conlin1, V T Fajtova, R M Mortensen, M S LeBoff, E M Brown.   

Abstract

We have used an immunoradiometric assay for intact PTH in conjunction with calcium and citrate infusions to study whether levels of intact PTH are responsive to reversal of the direction of change in ionized calcium in normal humans. Eleven normal subjects received graded infusions of citrate or calcium on separate days to produce linear rates of decrease or increase in calcium. After discontinuation of the infusions, the return of calcium toward baseline was followed. Six subjects were given an infusion of citrate after the calcium infusion to speed the recovery of calcium toward baseline. Citrate-induced hypocalcemia produced a rise in serum PTH levels from 28.1 +/- 3.6 to 69.4 +/- 4.8 ng/L as calcium fell from 1.26 +/- 0.01 to 1.06 +/- 0.02 mmol/L. As calcium returned toward baseline, PTH levels fell dramatically, reaching levels indistinguishable from baseline despite persistent hypocalcemia. Slopes of regression lines defining the PTH-calcium relationships during decreasing and increasing calcium levels were significantly different. Those subjects receiving a calcium infusion alone showed a prompt suppression of PTH levels. As calcium returned toward baseline after the infusion, a modest decline in calcium produced no significant change in the PTH-calcium relationship. When citrate was used to return calcium to baseline, PTH levels rose from 7.8 +/- 2.0 to 55.0 +/- 6.8 ng/L as calcium fell from 1.42 +/- 0.02 to 1.26 +/- 0.02 mmol/L and defined a regression relationship significantly different from the period of increasing calcium. Thus, a hysteretic relationship between ionized calcium and levels of intact PTH can be induced in normal humans by reversing the direction of change in calcium. Therefore, the role played by calcium concentration per se in controlling PTH secretion may be part of more complex and dynamic regulatory mechanisms.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2760172     DOI: 10.1210/jcem-69-3-593

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  8 in total

Review 1.  Motivations and methods for analyzing pulsatile hormone secretion.

Authors:  Johannes D Veldhuis; Daniel M Keenan; Steven M Pincus
Journal:  Endocr Rev       Date:  2008-10-21       Impact factor: 19.871

2.  The apparent hysteresis in hormone-agonist relationships.

Authors:  William A Pruett; Robert L Hester; Thomas G Coleman
Journal:  J Theor Biol       Date:  2011-12-03       Impact factor: 2.691

3.  Suppressibility of serum levels of PTH by calcium in the immediate postoperative period after surgery for primary hyperparathyroidism.

Authors:  A Bergenfelz; B Ahrén
Journal:  World J Surg       Date:  1993 Nov-Dec       Impact factor: 3.352

4.  Disodium ethylenediaminetetraacetate: adverse effects in dialyzed children.

Authors:  J A Ramirez; W G Goodman; C Menezes; G V Segre; I B Salusky
Journal:  Pediatr Nephrol       Date:  1993-04       Impact factor: 3.714

5.  Intact parathyroid hormone levels in renal insufficiency.

Authors:  V T Fajtova; M H Sayegh; N Hickey; P Aliabadi; J M Lazarus; M S LeBoff
Journal:  Calcif Tissue Int       Date:  1995-11       Impact factor: 4.333

Review 6.  The Calcium-Sensing Receptor and the Parathyroid: Past, Present, Future.

Authors:  Arthur D Conigrave
Journal:  Front Physiol       Date:  2016-12-15       Impact factor: 4.566

7.  A mathematical model of parathyroid gland biology.

Authors:  Gudrun Schappacher-Tilp; Alhaji Cherif; Doris H Fuertinger; David Bushinsky; Peter Kotanko
Journal:  Physiol Rep       Date:  2019-04

8.  Citrate dose for continuous hemofiltration: effect on calcium and magnesium balance, parathormone and vitamin D status, a randomized controlled trial.

Authors:  Willem Boer; Tom Fivez; Margot Vander Laenen; Liesbeth Bruckers; Hans Jurgen Grön; Miet Schetz; Heleen Oudemans-van Straaten
Journal:  BMC Nephrol       Date:  2021-12-11       Impact factor: 2.388

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.